News

Improving the efficacy of drug development: Another milestone agreement for biosensor technology

Biosensor technology co-developed by Dr. Stéphane Laporte, a scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), and...

A prescription with legs!

A study from the Research Institute of the McGill University Health Centre (RI-MUHC) shows that physician-delivered step count...

Congratulations!

Congratulations to Dr. Stéphane Laporte and his collaborators on the recent licensing to the biopharmaceutical company Alkermes of...

New marker identified for pancreatic cancer

Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...

Antidepressants: rise in off-label prescriptions

Antidepressant use in North America has increased over the last 2 decades. A suspected reason for this trend is that primary care physicians are increasingly prescribing...

Brain cells that aid appetite control identified

It’s rare for scientists to get what they describe as “clean” results without spending a lot of time repeating the same experiment over and over again.